封面
市場調查報告書
商品編碼
2039025

吡咯烯檢測市場:依檢測類型、產品類型、最終用戶和地區分類

Pyrogen Testing Market, By Test Type, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,2026年熱熱測試市場價值為14.7億美元,預計到2033年將達到28.9億美元。預計從2026年到2033年,其複合年成長率將達到10.1%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 14.7億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 10.10% 2033年市場規模預測: 28.9億美元

致熱物質檢測用於檢測藥品和醫療設備中存在的致熱原。受污染的醫療設備或藥品進入人體後可能引起發燒、休克、發炎和其他問題。致熱物質檢測包括試劑盒、試劑和儀器,可實現致熱原和內毒素的體外檢測,從而最大限度地減少動物試驗的使用。

2012年6月,美國食品藥物管理局(FDA)發布了關於熱原和內毒素檢測的產業指南。因此,政府嚴格的監管以及對體外熱原檢測方法的日益重視,成為推動市場成長的主要因素。

市場動態

參與企業專注於研發包括癌症在內的各種疾病的治療方法,而這些藥物的生產則需要進行熱原性測試。因此,藥物研發的成長預計將推動全球熱原性測試市場的發展。例如,2019年4月,專注於研發糖尿病和癌症細胞療法的生物技術公司PharmaCyte Biotech, Inc.宣布,其用於生產Cell-in-a-Box膠囊(CypCaps)的封裝材料已通過熱原性測試。

此外,根據 2019 年醫藥研發年度回顧,2019 年在研藥物數量估計約為 16,181 種,與 2018 年的約 15,267 種相比,整體在研藥物數量增加了 6%。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數分析了全球熱熱測試市場的主要參與者:公司概況、財務績效、產品系列、市場地位、分銷策略、關鍵發展、策略和未來計劃。
  • 透過利用本報告中的見解,企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球熱熱測試市場報告的目標受群眾外包括該行業的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球熱熱測試市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 研究目標
  • 前提
  • 簡稱

第2章 市場範圍

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機遇
  • 影響分析
  • 主要進展
  • PEST分析

第4章 全球吡喃酮檢測市場:依檢測類型分類,2021-2033年

  • 鱟變形蟲裂解物(LAL)試驗
  • TAL測試
  • 單核細胞活化試驗(MAT)
  • 兔促熱素試驗(RPT)
  • 重組因子C檢測(rFC)

第5章 全球吡咯烯檢測市場:依產品類型分類,2021-2033年

  • 裝置
  • 成套工具
  • 試劑

第6章 全球吡咯烯檢測市場:依最終用戶分類,2021-2033年

  • 製藥和生物技術公司
  • 食品和飲料公司
  • 其他

第7章 全球吡咯烯檢測市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 中非
    • 北非

第8章 競爭情勢

  • 熱圖分析
  • 市佔率分析
    • Thermo Fisher Scientific
    • Merck KGaA
    • Lonza Group
    • Associates of Cape Cod Inc
    • Charles River Laboratories Inc
    • GenScript
    • WuXi PharmaTech(Cayman), Inc
    • bioMerieux
    • Wako Chemicals USA, Inc
    • Sanquin
    • Ellab A/S
    • Pyrostar

第9章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI243

Pyrogen Testing Market is estimated to be valued at USD 1.47 Bn in 2026 and is expected to reach USD 2.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1.47 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.10% 2033 Value Projection: USD 2.89 Bn

Pyrogen testing is detection of pyrogen in pharmaceutical drugs and devices. The contaminated devices or drugs when introduced in body can cause fever, shock, inflammation, and other problems. Pyrogen testing consists of kits, reagents, and instruments, which enable pyrogen and endotoxins detection by in-vitro methods and minimizes the usage of animal testing.

In June 2012, the U.S. Food and Drug Administration (FDA) provided guidelines for pyrogen and endotoxin testing to industries. Hence, stringent government regulations and rising focus on in-vitro testing for detection of pyrogen are major factors boosting growth of the market.

Market Dynamics

Market players are focusing on development of drugs for the treatment of various diseases such as cancer, which requires pyrogen testing in order to manufacture the drugs. Hence, increasing drug development is expected to boost growth of the global pyrogen testing market. For instance, in April 2019, PharmaCyte Biotech, Inc., a biotechnology company focused on development of cellular therapies for diabetes and cancer, announced that it cleared the pyrogenicity testing of the encapsulation material to manufacture Cell-in-a-Box capsules (CypCaps).

Moreover, according to the Pharma R&D Annual Review, 2019, an estimated number of drugs under pipeline in 2019 was around 16,181, while in 2018, it was around 15,267, resulting in an overall pipeline growth by 6% in 2018.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pyrogen testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMerieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pyrogen testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pyrogen testing market.

Market Segmentation

  • Global Pyrogen Testing Market, By Test Type
    • Limulus Amoebocyte Lysate (LAL) Test
    • TAL Test
    • Monocyte Activation Test (MAT)
    • Rabbit Pyrogen Test (RPT)
    • Recombinant Factor C Assay (rFC)
  • Global Pyrogen Testing Market, By Product Type
    • Instruments
    • Kits
    • Reagents
  • Global Pyrogen Testing Market, By End User
    • Pharmaceutical and Biotech Companies
    • Food and Beverages Companies
    • Others
  • Global Pyrogen Testing Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
    • Thermo Fisher Scientific,
    • Merck KGaA,
    • Lonza Group,
    • Associates of Cape Cod Inc,
    • Charles River Laboratories Inc,
    • GenScript,
    • WuXi PharmaTech (Cayman), Inc,
    • bioMerieux,
    • Wako Chemicals USA, Inc,
    • Sanquin, Ellab A/S,
    • Pyrostar

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Developments
  • PEST Analysis

4. Global Pyrogen Testing Market, By Test Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2021 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Limulus Amoebocyte Lysate (LAL) Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • TAL Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Monocyte Activation Test (MAT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Rabbit Pyrogen Test (RPT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Recombinant Factor C Assay (rFC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Pyrogen Testing Market, By Product Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2021 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Pyrogen Testing Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2021 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pharmaceutical and Biotech Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Food and Beverages Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Pyrogen Testing Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2033
  • North America
    • Market Size and Forecast, By Test Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Test Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Test Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Test Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Test Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Test Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
      • South Africa
      • Central Africa
      • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Thermo Fisher Scientific
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Merck KGaA
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Lonza Group
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Associates of Cape Cod Inc
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Charles River Laboratories Inc
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • GenScript
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • WuXi PharmaTech (Cayman), Inc
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • bioMerieux
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Wako Chemicals USA, Inc
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Sanquin
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Ellab A/S
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Pyrostar
      • Company Overview
      • Device Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
      • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact